ACM
EXAS

Atika Capital Management’s Exact Sciences EXAS Stock Holding History

Atika Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,600
Closed -$11M – 101
2024
Q1 		$11M Buy
+1,600
New +$101K 1.09% 36
2019
Q1 		– Sell
-44,100
Closed -$2.78M – 80
2018
Q4 		$2.78M Buy
+44,100
New +$3.03M 0.82% 48

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Atika Capital Management's EXAS Position: Q3 2024 in Review

Atika Capital Management sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 211,120 shares — an estimated $8.92M sold.

Atika Capital Management first reported a position in EXAS in Q3 2016 and held it in 24 quarters. The position peaked at $22.8M in Q2 2023. 599 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Atika Capital Management reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Atika Capital Management sold 211,120 Exact Sciences shares in Q3 2024, an estimated $8.92M.
  • Atika Capital Management first reported a position in Exact Sciences in Q3 2016 and held it in 24 quarters.
  • Atika Capital Management's Exact Sciences position peaked at $22.8M in Q2 2023.
  • 599 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Atika Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.